General Information
BounceWatch is an independent company data service, not affiliated with RevBio, Inc.. To contact RevBio, Inc., visit revbio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does RevBio, Inc. compare?
A PDF of RevBio, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting RevBio, Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is RevBio, Inc. on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About RevBio, Inc.
Business keywords: Medicine, Biomaterials, Medical Device, Dental, Veterinary, Biomimetics, Bone Graft, Orthopaedics, Prosthodontics, Oral Surgery, Neurosurgery, Innovation, Bone Repair, Biocompatible Adhesive, Trauma
Funding Rounds & Investors (15)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $2.00M | 1 |
National Institutes of Health
|
25 Oct 2023 |
| Grant | $3.40M | 1 |
National Institute on Aging
|
06 Oct 2023 |
| Grant | $2.00M | 1 |
National Institute of Dental and Craniofacial Research (NIDCR)
|
07 Jun 2023 |
| Corporate Round | Undisclosed | 1 | 14 Feb 2023 | |
| Grant | Undisclosed | 1 |
National Institute on Aging
|
20 Sep 2022 |
| Non Equity Assistance | Undisclosed | 1 | 07 Jun 2022 | |
| Seed Round | $9.01M | - |
|
11 Jun 2021 |
| Grant | $1.80M | 1 | 02 Jun 2020 | |
| Grant | $2.50M | 1 |
National Institute of Neurological Disorders and Stroke
|
05 May 2020 |
| Seed Round | $9.50M | - |
|
21 Dec 2019 |
RevBio, Inc. Alternatives & Competitors
View All AlternativesGlobal Leader in Synthetic & Resorbable Biomaterials
MIS COREX™ is designed to capture and preserve cancellous autograft with one simple mechanism.
Founded in 2005, Graftys develops, manufactures and markets patented synthetic bone biomaterials, in...
FAQ About RevBio, Inc.
Source: BounceWatch company record for RevBio, Inc., https://bouncewatch.com/company/revbio-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.